Menu
Not yet recruiting NCT07502950

ROTEM Interpretation AI vs Experts

Observational Coagulopathy Thromboelastography Agreement

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Large Language Model (LLM) artificial intelligence assesment.
Who it may be relevant to
Registry conditions: Coagulopathy, Thromboelastography, Agreement. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Artificial Intelligence Versus Expert Interpretation of ROTEM: A Prospective Study of Agreement and Clinical Decision-Making

Overview

This prospective multicenter observational study aims to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings in clinically relevant settings. ROTEM is widely used to guide hemostatic therapy in perioperative and critically ill patients, but its interpretation is complex and subject to interobserver variability. The primary objective is to determine whether AI-based interpretation achieves agreement comparable to variability between expert clinicians. Secondary objectives include comparison of interpretation time, assessment of consistency of AI outputs, and evaluation of potential differences in clinical decision-making. ROTEM datasets will be independently assessed by multiple expert anesthesiologists and by an AI-based model using standardized input. Agreement between methods and variability of interpretation will be analyzed. The study aims to determine whether AI-assisted interpretation could serve as a reliable decision-support tool and reduce variability in ROTEM-guided clinical practice.

Detailed description

This prospective multicenter observational study is designed to evaluate the agreement between artificial intelligence (AI)-based interpretation and expert interpretation of rotational thromboelastometry (ROTEM) findings, with a focus on clinical decision-making in critically ill patients.

ROTEM is a point-of-care viscoelastic method providing real-time information on coagulation, including clot formation, strength, and fibrinolysis. It is widely used to guide targeted hemostatic therapy in trauma, major surgery, and critical care. However, interpretation of ROTEM findings is complex and requires clinical expertise. Interobserver variability among clinicians may lead to inconsistent therapeutic decisions. Although algorithm-based approaches have been introduced, their implementation remains variable.

Artificial intelligence (AI) has the potential to standardize interpretation by integrating multiple ROTEM parameters and generating consistent recommendations. Previous studies have shown that machine learning models can predict clinical outcomes or transfusion requirements based on viscoelastic data. However, evidence on agreement between AI-based interpretation and expert interpretation, particularly in real-world clinical decision-making, remains limited.

The primary objective of this study is to determine whether AI-based interpretation achieves a level of agreement comparable to inter-expert variability in ROTEM interpretation. This study does not assume a single gold standard; instead, it evaluates agreement between methods, reflecting real-world clinical practice.

Secondary objectives include:

* comparison of interpretation time between AI and expert clinicians, * assessment of consistency (intra-method variability) of AI compared to inter-expert variability, * evaluation of potential impact on clinical decision-making, including identification of coagulation abnormalities and proposed treatment strategies.

ROTEM measurements will be collected and presented in a standardized format, including graphical and numerical outputs. Each dataset will be independently evaluated by multiple expert anesthesiologists. The same datasets will be interpreted repeatedly by an AI-based large language model using a predefined standardized prompt, with multiple independent runs to assess intra-model variability.

For each ROTEM dataset, both experts and AI will assess:

* presence of a coagulation disorder, * dominant underlying abnormality, * appropriate therapeutic intervention, * and recommended treatment dose.

Agreement between experts and AI, as well as inter-expert agreement, will be analyzed using appropriate statistical methods for categorical and continuous variables (e.g., kappa statistics and intraclass correlation coefficients). Time required for interpretation will also be recorded and compared.

This study is not designed to determine the absolute correctness of interpretation, but to quantify agreement and variability between human experts and AI. By identifying clinically relevant discrepancies, the study aims to evaluate whether AI-assisted interpretation may serve as a reliable decision-support tool and reduce variability in ROTEM-guided hemostatic management.

Interventions

  • Other Large Language Model (LLM) artificial intelligence assesment
    The thromboelastography record will be assessed by LLM based artificial intelligence.

Primary outcome measures

  • Agreement between AI-based and expert interpretation of ROTEM findings [Time frame: Up to 24 hours after ROTEM measurement (time required for interpretation and data recording).]
Secondary outcome measures (4)
  • Interpretation time [Time frame: Up to 24 hours after ROTEM measurement.]
  • Consistency of interpretation (intra-method variability) [Time frame: Up to 24 hours after ROTEM measurement]
  • Proportion of clinically discordant decisions [Time frame: Up to 24 hours after ROTEM measurement]
  • Inter-expert agreement [Time frame: Up to 24 hours after ROTEM measurement]

Eligibility criteria

Inclusion criteria

Adult patients (age ≥18 years)

  • ROTEM analysis performed using a ROTEM Sigma device as part of routine clinical care
  • Availability of complete ROTEM output (graphical and numerical data)
  • ROTEM measurement obtained in a clinical context where assessment of coagulation status is indicated (e.g., perioperative setting, trauma, or critical illness)

Exclusion criteria

  • ROTEM measurements performed using the HEPTEM channel
  • Incomplete or missing ROTEM data preventing standardized evaluation
  • ROTEM measurements obtained under non-standardized or technically unreliable conditions

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07502950 · ROTEMAI

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗